A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Partner of Industry and Medical Professionals for Ophthalmic Market Data, Primary Research, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 350
Comprehensive Pages
- 40
Competitor Profiles
- 11
IOL Categories Forecasted
- 8
Geographic/Economic Breakouts
2022 IOL Market Report: Global Analysis for 2021 to 2027, April, 2022
The “2022 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.
Latest Industry News & Trends
11/23/2022
AcquisitionsBreakingCataractDealsSurgical
Sightpath Acquires Accusite to Expand Mobile Footprint
Sightpath Medical, of Bloomington, Minnesota, announced Nov. 21 that it had acquired another mobile cataract surgery equipment provider, Accusite Surgical. No financial details were provided. Sight...
11/23/2022
BreakingClinical TrialGene TherapyRetina
Editas Pauses CRISPR/Cas9 Gene Therapy Trial for LCA10 Due to Disappointing Results
Editas Medicine of Cambridge, Massachusetts, reported Nov. 17 that it would pause enrollment in its Phase I/II BRILLIANCE trial of EDIT-101 for the treatment of Leber congenital amaurosis 10 (LCA10...
11/23/2022
BreakingRegulationRetina
US FDA Accepts Apellis’ NDA Amendment for Pegcetacoplan in GA; Iveric’s Zimura Granted Breakthrough Status
Apellis announced Nov. 18 that the US FDA had accepted its amended new drug application (NDA) in geographic atrophy (GA) for pegcetacoplan, a complement C3 inhibitor, with 24-month efficacy data fr...
11/21/2022
CataractIOLNewsletterPremium
Improved PC-IOL Technology is Key to Recent and Future Premium Cataract Surgery Growth
Presbyopia-correcting IOL technology improvements have led to almost a doubling of global units over the past five years and will be critical to driving future growth over the next five years. In 2...
11/23/2022
BreakingRefractiveSurgical
STAAR Surgical Opens First EVO Experience Center in US
STAAR Surgical reported Nov. 21 that it had opened the first US-based EVO Experience Center, located at the company’s headquarters in Lake Forest, California. STAAR said the center is similar to EV...
11/23/2022
BreakingGenericsGlaucoma
Prasco Launches Authorized Generic of Zioptan (Tafluprost) Drops for Glaucoma
Prasco Laboratories announced Nov. 18 that it had launched an authorized generic version of Zioptan (tafluprost ophthalmic solution) 0.0015% for glaucoma. Prasco, of Mason, Ohio, said it was its fi...
11/23/2022
BreakingClinical TrialDry EyeRegulation
OKYO Files IND with US FDA for Phase II Trial of Dry Eye Candidate
London’s OKYO Pharma announced Nov. 21 that it had filed an investigational new drug (IND) application with the US FDA for its topical dry eye treatment candidateOK-101. The company said it had des...
11/21/2022
Dry EyeNewsletter
New Products Shake Up Dry Eye Market, Pressure Leaders
New products are changing the landscape of dry eye treatment. Longtime favorites face competition from less expensive alternatives on one side and more specialized treatments on the other. Perennia...
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Over 500 Clients, Large & Small, Have Trusted Market Scope Data & Analysis
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.